BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9664765)

  • 1. A diffusible resistance factor(s) in spontaneous mitomycin resistant mammalian cancer cells.
    Wan ZG; Kobayashi H; Hayakawa A; Ishigaki T
    Nagoya J Med Sci; 1998 May; 61(1-2):37-45. PubMed ID: 9664765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-irradiation exposure to HBSS enhances apoptosis in FM3A cells.
    Zhu WG; Antoku S; Sasaki H; Dynlacht JR
    Anticancer Res; 1998; 18(6A):4043-9. PubMed ID: 9891443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
    Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
    Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synergistic antitumor effect of sodium caffeate and mitomycin].
    Xu F; Song DQ; Zhen YS
    Yao Xue Xue Bao; 2002 Jun; 37(6):405-8. PubMed ID: 12579792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells.
    Wallner KE; Banda M; Li GC
    Cancer Res; 1987 Mar; 47(5):1308-12. PubMed ID: 3102043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.
    Takeuchi H; Baba H; Maehara Y; Sugimachi K; Newman RA
    Cancer Chemother Pharmacol; 1996; 38(1):1-8. PubMed ID: 8603441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cellular target for mitomycin C: a case for mitochondrial DNA.
    Pritsos CA; Briggs LA; Gustafson DL
    Oncol Res; 1997; 9(6-7):333-7. PubMed ID: 9406239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of epirubicin hydrochloride (EPI) plus pretreatment of medroxyprogesterone acetate (MPA) on FM3A breast cancer cells transplanted in female C3H/He mice.
    Yuyama Y; Yagihashi A; Hirata K; Suzuki Y; Ohmura T; Okazaki M; Watanabe N
    In Vivo; 2003; 17(3):251-4. PubMed ID: 12929575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
    Zhao GZ; Tan WL; Zheng SB; Wu YD; Xie Y; Zhu WH
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
    Cheung RY; Rauth AM; Ronaldson PT; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2006 Apr; 62(3):321-31. PubMed ID: 16330194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.
    Willson JK; Long BH; Marks ME; Brattain DE; Wiley JE; Brattain MG
    Cancer Res; 1984 Dec; 44(12 Pt 1):5880-5. PubMed ID: 6437674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of resistance to mitomycin C in a human bladder cancer cell line].
    Xu B; Sun Y; Singh SV
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):343-6. PubMed ID: 8697971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a mouse FM3A cell mutant resistant to topoisomerase II-inhibitor NC-190.
    Samata K; Yamagishi T; Ichihara T; Nanaumi K; Ikeda T; Ikeya H; Kuraishi A; Nakaike S; Kashiwagi K; Igarashi K
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):367-72. PubMed ID: 12439594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation resistance in a melphalan-resistant subline of a rat mammary carcinoma.
    Lehnert S; Vestergaard J; Batist G; Aloui-Jamali MA
    Radiat Res; 1994 Aug; 139(2):232-9. PubMed ID: 8052700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of change in cellular GSH levels on mitochondrial damage and cell viability loss due to mitomycin c in small cell lung cancer cells.
    Lee CS; Park SY; Ko HH; Han ES
    Biochem Pharmacol; 2004 Nov; 68(9):1857-67. PubMed ID: 15450951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.
    Rockwell S
    J Natl Cancer Inst; 1983 Oct; 71(4):765-71. PubMed ID: 6413743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.
    Kang CD; Ahn BK; Jeong CS; Kim KW; Lee HJ; Yoo SD; Chung BS; Kim SH
    Exp Cell Res; 2000 Apr; 256(1):300-7. PubMed ID: 10739677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-mediated transfer of a human gene that confers resistance to mitomycin C.
    Buchwald M; Clarke C
    J Cell Physiol; 1991 Sep; 148(3):472-8. PubMed ID: 1918174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity to mitomycin C between human RSa cell line and its derivative UVr-1.
    Hiwasa T; Chen Z; Nomura J; Yamamori H; Tashiro T; Nakajima N; Suzuki N
    Anticancer Res; 1999; 19(5B):3915-20. PubMed ID: 10628331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugates of mitomycin C with the immunoglobulin M monomer fragment of a monoclonal anti-MM46 immunoglobulin M antibody with or without serum albumin as intermediary.
    Umemoto N; Kato Y; Takeda Y; Saito M; Hara T; Seto M; Takahashi T
    J Appl Biochem; 1984; 6(5-6):297-307. PubMed ID: 6443109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.